MEDICLINIC INTERNATIONAL PLC

Board/Management Information • Apr 8, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5533U

Mediclinic International PLC

08 April 2016

Mediclinic International plc (the "Company")

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

8 April 2016

Appointment of Alternate Director

The Board of Mediclinic International plc is pleased to announce that as of 7 April 2016, Mr Jannie Durand, a non-executive director of the Company, has appointed Mr Pieter Uys as his alternate director.

Since 2013, Mr Uys has held the position of Head of Strategic Investment at Remgro Limited, a Johannesburg Stock Exchange listed investment company with meaningful interests in a number of businesses across the world. Prior to joining Remgro, Mr Uys was a founding member and ultimately became the CEO of Vodacom Group, one of the leading mobile networks in Africa. Mr Uys holds a MEng (Electrical) and an MBA from the University of Stellenbosch, South Africa.

There is no further information to be disclosed in accordance with Listing Rule 9.6.

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information, please contact:

Company Secretary

Victoria Dalby               

Capita Company Secretarial Services Limited

+44 (0)207 954 9528

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSSEFIWFMSEEL